Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Item Type
      Item Type
      Clear All
      Item Type
  • Subject
      Subject
      Clear All
      Subject
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Source
    • Language
1,760 result(s) for "Robson, Mark"
Sort by:
Reviewers for the Journal, July–December 2013
Each year thousands of reviewers contribute their expertise to peer review, a process that contributes critically to the quality of the Journal . The editors and the authors of the papers submitted to the Journal are grateful for the help of all our reviewers. Here we acknowledge, with special thanks, those who reviewed two or more papers between July and December 2013. Michael J. Zinner Benjamin Abella Jonathan D. Adachi John W. Adamson Nezam Afdhal Guruprasad Aithal Graciela S. Alarcon David Alland Gerard F. Anderson Jeffrey L. Anderson Joseph H. Antin Paul S. Appelbaum Wiebke Arlt Scott A. Armstrong Jorge . . .
USPSTF: Screen women with increased risk for BRCA1, BRCA2 mutations
The U.S. Preventive Services Task Force recommended physicians screen women with a familial risk assessment tool if they have family history of breast, ovarian, tubal or peritoneal cancer or an ancestry associated with BRCA1 or BRCA2 mutations. The recommendations mirror the 2013 USPSTF recommendations for screening, but more evidence has emerged since then, Owens noted. \"Since 2013, the validity of genetic testing for BRCA1/2 mutations has been established and the potential benefits and harms of previously reviewed interventions, such as risk-reducing medications and surgery, have been studied for longer follow-up periods,\" Owens and colleagues wrote. [...]although primary care clinicians are the ideal group to assess risk and make appropriate referrals for genetic counseling, it will be important to assess the feasibility of use of the recommended familial risk assessment tools among these busy clinicians, who already have many other demands and time restraints while in clinic. -
Acknowledgement to Reviewers of Beverages in 2016
The editors of Beverages would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2016. We greatly appreciate the contribution of expert reviewers, which is crucial to the journal’s editorial process. We aim to recognize reviewer contributions through several mechanisms, of which the annual publication of reviewer names is one. Reviewers receive a voucher entitling them to a discount on their next MDPI publication and can download a certificate of recognition directly from our submission system. Additionally, reviewers can sign up to the service Publons (https://publons.com) to receive recognition. Of course, in these initiatives we are careful not to compromise reviewer confidentiality. Many reviewers see their work as a voluntary and often unseen part of their role as researchers. We are grateful to the time reviewers donate to our journals and the contribution they make.